Back to User profile » Dr Takeshi Okanoue
Paper published by Dr Takeshi Okanoue:
Original Research
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y
Diabetes, Metabolic Syndrome and Obesity 2018, 11:835-843
Published Date: 27 November 2018